Current Issue

Rheumatoid arthritis

• Original research: Effects of employees living with an ‘arthritis’ on sickness absence and transitions out of employment: a comparative observational study in the UK (29 November, 2024)

  William Whittaker, James Higgerson, Martin Eden, Katherine Payne, Ross Wilkie, Suzanne MM Verstappen
• Original research: Biomechanical determinants of rheumatoid arthritis severity and excess cardiovascular disease: common origins of two complex diseases (21 November, 2024)

  Stephen Philip Oakley, Samantha Stott, Kerri Gill, Lyanne Weston
• Original research: Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis (18 November, 2024)

  Sara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, Alexandra Cîrciumaru, Christina Gerstner, Linda Mathsson-Alm, Bruno Raposo, Anatoly Dubnovitsky, Lars Rönnblom, William W Kwok, Karine Chemin, Vivianne Malmström, Aase Hensvold
• Original research: Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis (17 November, 2024)

  Patrick Vandormael, Sukayna Fadlallah, Pieter Ruytinx, Astrid Pues, Ellen Sleurs, Jori Liesenborgs, Johan Joly, Anouk Agten, Frank Vandenabeele, Judith Fraussen, Patrick Verschueren, Veerle Somers
• Original research: Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia? (12 November, 2024)

  Stijn Claassen, Anna M P Boeren, Sarah J H Khidir, Hanna W van Steenbergen, Annette H M van der Helm-van Mil
• Original research: Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient data (7 November, 2024)

  Catia Duarte, Johannes W G Jacobs, Ricardo J O Ferreira, Paco M J Welsing, Laure Gossec, Pedro M Machado, Désirée van der Heijde, Jose Antonio Pereira da Silva
• Original research: Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-γR/STAT1 pathway in the treatment of rheumatoid arthritis (7 November, 2024)

  Yao Teng, Haifeng Yin, Ruizhi Feng, Lijuan Jiang, Wenlin Qiu, Xiaoru Duan, Xuefei Wang, Guo-Min Deng
• Original research: Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins (26 October, 2024)

  Amir A Razmjou, Joel M Kremer, Dimitrios A Pappas, Jeffrey R Curtis, Jennifer Wang, Ani Shahbazian, David A Elashoff, Rong Guo, David Meriwether, Dawoud Sulaiman, Ellen O'Connor, Srinivasa T Reddy, Christina Charles-Schoeman
• Original research: Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study (24 October, 2024)

  Maya H Buch, Daniel Aletaha, Bernard G Combe, Yoshiya Tanaka, Roberto Caporali, Hendrik Schulze-Koops, Tsutomu Takeuchi, Jacques-Eric Gottenberg, Ricardo Blanco, Patrick Verschueren, Anna Zubrzycka-Sienkiewicz, Francesco De Leonardis, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Emery
• Clinical case: Sustained drug-free remission in rheumatoid arthritis associated with diffuse large B-cell lymphoma following tandem CD20-CD19-directed non-cryopreserved CAR-T cell therapy using zamtocabtagene autoleucel (23 October, 2024)

  David Szabo, Alexandra Balogh, Laszlo Gopcsa, Laura Giba-Kiss, Gergely Lakatos, Melinda Paksi, Marienn Reti, Peter Takacs, Pearl van Heteren, Gregor Zadoyan, Silke Holtkamp, Toon Overstijns, Stefan Miltenyi, Peter Remenyi, György Nagy
• Original research: Comparing outcomes of patients with early active rheumatoid arthritis initially treated on an inpatient or outpatient basis: a posthoc analysis of the CORRA trial (22 October, 2024)

  Anna Mai, Dietmar Krause, Renate Klaassen-Mielke, Katharina Meiszl, Nina Timmesfeld, Xenofon Baraliakos, Jürgen Braun
• Original research: Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47 (18 October, 2024)

  Josef S Smolen, Jakub Trefler, Artur Racewicz, Janusz Jaworski, Agnieszka Zielińska, Marek Krogulec, Sławomir Jeka, Rafał Wojciechowski, Katarzyna Kolossa, Anna Dudek, Magdalena Krajewska-Włodarczyk, Paweł Hrycaj, Piotr Adrian Klimiuk, Gerd R Burmester, SungHyun Kim, YunJu Bae, GoEun Yang, YooBin Jung, JiWoo Hong, Edward Keystone
• Original research: The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study (18 October, 2024)

  Giulia Frazzei, Sophie H M Cramer, Robert B M Landewé, Karen I Maijer, Danielle M Gerlag, Paul P Tak, Niek de Vries, Lisa G M van Baarsen, Ronald F van Vollenhoven, Sander W Tas
• Letter: Immune reactivity directed against the carbamylated fibrinogen α chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritis (10 October, 2024)

  Pauline Brevet, Olivier Boyer, Olivier Vittecoq, Manuel Fréret
• Original research: Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID (7 October, 2024)

  Laura Y L Kummer, Laura Fernández Blanco, Christine Kreher, Amélie Bos, Lisan H Kuijper, Niels J M Verstegen, Carolien E van de Sandt, Veronique A L Konijn, Mariël C Duurland, Charlotte Menage, Tineke Jorritsma, Maurice Steenhuis, Ruth R Hagen, Jet van den Dijssel, Rivka de Jongh, Tom Ashhurst, Marit J van Gils, Juan J Garcia-Vallejo, Mathieu Claireaux, Eileen W Stalman, Koos P J van Dam, Luuk Wieske, Laura Boekel, Gertjan Wolbink, Sander W Tas, Theo Rispens, Taco W Kuijpers, Filip Eftimov, Sija Marieke van Ham, Anja ten Brinke
• Original research: Systematic screening for multimorbidities in patients with inflammatory rheumatic diseases enhanced preventive medication use and reduced hospitalisations: an exposed-non-exposed study (2 October, 2024)

  Claire Immediato Daien, Vera Georgescu, Guillaume Decarriere, Grégoire Mercier, Jacques Morel
• Original research: Forefoot inflammation in recent-onset ACPA-positive and ACPA-negative RA: clinically similar, but different in underlying inflamed tissues (2 October, 2024)

  Dennis A. Ton, Bastiaan T. van Dijk, Hanna W. van Steenbergen, Annette H.M. van der Helm - van Mil